Cluster-randomized Trial to Evaluate the Impact of Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Meningococcal meningitis
- Focus Therapeutic Use
- 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 23 Apr 2017 Planned End Date changed from 1 Jul 2017 to 31 Dec 2017.
- 23 Apr 2017 Planned primary completion date changed from 1 May 2017 to 30 Jun 2017.